Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Feb;49(2):112–115. doi: 10.1136/jcp.49.2.112

Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.

H Osawa 1, F Inoue 1, Y Yoshida 1
PMCID: PMC500341  PMID: 8655674

Abstract

AIMS: To clarify the relation between the serum titre of anti-Helicobacter pylori (H pylori) antibody and the extent of intestinal metaplasia of the gastric mucosa. METHODS: The serum anti-H pylori IgG titres of 95 asymptomatic individuals (mean age 65 years) undergoing an annual health examination were measured and compared with the extent of intestinal metaplasia (absent, moderate, or extensive), determined by examination of multiple endoscopic mucosal biopsy specimens. Serum pepsinogen I (PGI) levels, as a marker for gastric atrophy, were also measured. RESULTS: The prevalence of seropositivity for H pylori antibody was high (> 80%), regardless of the extent of metaplasia. However, there was a negative association between the extent of metaplasia and the anti-H pylori titre: 75% of the subjects in the group without metaplasia had high (3+) antibody levels, as did 43% with moderate, and 37% with extensive metaplasia (absent v extensive). The inverse relation between the titre and the extent of metaplasia was evident when examined in those with normal PGI (> 30 ng/ml), whereas no such relation was apparent in subjects with low PGI (< or = 30 ng/ml). CONCLUSIONS: The anti-H pylori titre correlates inversely with the extent of intestinal metaplasia, particularly in subjects with less marked gastric atrophy.

Full text

PDF
112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asaka M., Kimura T., Kudo M., Takeda H., Mitani S., Miyazaki T., Miki K., Graham D. Y. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992 Mar;102(3):760–766. doi: 10.1016/0016-5085(92)90156-s. [DOI] [PubMed] [Google Scholar]
  2. Correa P. Precursors of gastric and esophageal cancer. Cancer. 1982 Dec 1;50(11 Suppl):2554–2565. [PubMed] [Google Scholar]
  3. Craanen M. E., Blok P., Dekker W., Ferwerda J., Tytgat G. N. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992 May;33(5):597–600. doi: 10.1136/gut.33.5.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crabtree J. E., Shallcross T. M., Heatley R. V., Wyatt J. I. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol. 1991 Apr;44(4):326–328. doi: 10.1136/jcp.44.4.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graham D. Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):615–625. doi: 10.1016/s0016-5085(89)80057-5. [DOI] [PubMed] [Google Scholar]
  6. Hoek F. J., Noach L. A., Rauws E. A., Tytgat G. N. Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum. J Clin Microbiol. 1992 Jun;30(6):1525–1528. doi: 10.1128/jcm.30.6.1525-1528.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Howson C. P., Hiyama T., Wynder E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27. doi: 10.1093/oxfordjournals.epirev.a036288. [DOI] [PubMed] [Google Scholar]
  8. Ichinose M., Miki K., Furihata C., Kageyama T., Hayashi R., Niwa H., Oka H., Matsushima T., Takahashi K. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta. 1982 Dec 9;126(2):183–191. doi: 10.1016/0009-8981(82)90034-1. [DOI] [PubMed] [Google Scholar]
  9. Johnston B. J., Reed P. I., Ali M. H. Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut. 1986 Oct;27(10):1132–1137. doi: 10.1136/gut.27.10.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kosunen T. U., Seppälä K., Sarna S., Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992 Apr 11;339(8798):893–895. doi: 10.1016/0140-6736(92)90929-w. [DOI] [PubMed] [Google Scholar]
  11. Marshall B. J., Warren J. R., Francis G. J., Langton S. R., Goodwin C. S., Blincow E. D. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol. 1987 Mar;82(3):200–210. [PubMed] [Google Scholar]
  12. Miki K., Ichinose M., Shimizu A., Huang S. C., Oka H., Furihata C., Matsushima T., Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn. 1987 Apr;22(2):133–141. doi: 10.1007/BF02774209. [DOI] [PubMed] [Google Scholar]
  13. Newell D. G., Johnston B. J., Ali M. H., Reed P. I. An enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand J Gastroenterol Suppl. 1988;142:53–57. doi: 10.3109/00365528809091714. [DOI] [PubMed] [Google Scholar]
  14. Parsonnet J., Vandersteen D., Goates J., Sibley R. K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991 May 1;83(9):640–643. doi: 10.1093/jnci/83.9.640. [DOI] [PubMed] [Google Scholar]
  15. Rathbone B. J., Wyatt J. I., Worsley B. W., Shires S. E., Trejdosiewicz L. K., Heatley R. V., Losowsky M. S. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut. 1986 Jun;27(6):642–647. doi: 10.1136/gut.27.6.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Samloff I. M., Varis K., Ihamaki T., Siurala M., Rotter J. I. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982 Jul;83(1 Pt 2):204–209. [PubMed] [Google Scholar]
  17. Stemmermann G. N., Samloff I. M., Nomura A. M., Heilbrun L. K. Serum pepsinogens I and II and stomach cancer. Clin Chim Acta. 1987 Mar 16;163(2):191–198. doi: 10.1016/0009-8981(87)90022-2. [DOI] [PubMed] [Google Scholar]
  18. Tsutsumi Y., Nagura H., Watanabe K. Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1984;403(4):345–359. doi: 10.1007/BF00737285. [DOI] [PubMed] [Google Scholar]
  19. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  20. Wyatt J. I., Rathbone B. J., Heatley R. V. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol. 1986 Aug;39(8):863–870. doi: 10.1136/jcp.39.8.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wyatt J. I., Shallcross T. M., Crabtree J. E., Heatley R. V. Helicobacter pylori, gastritis, and peptic ulceration in the elderly. J Clin Pathol. 1992 Dec;45(12):1070–1074. doi: 10.1136/jcp.45.12.1070. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES